Tempus AI, Inc. (TEM) Financial Analysis & Valuation | Quarter Chart
Tempus AI, Inc. (TEM)
TEMPrice: $58.31
Fair Value: 🔒
🔒score
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology ... more
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation... more
Description
Shares
| Market Cap | $10.18B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Eric Lefkofsky |
| IPO Date | 2024-06-14 | CAGR | 0.65% |
| Employees | 3,800 | Website | www.tempus.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.02% | Total Yield | 0.02% |
TEM chart loading...
Fundamentals
Technicals
| Enterprise Value | $10.30B | P/E Ratio | -116.62 |
| Forward P/E | -546.64 | PEG Ratio | — |
| P/S Ratio | 9.19 | P/B Ratio | 30.87 |
| P/CF Ratio | -69.19 | P/FCF Ratio | -57.93 |
| EPS | $-0.5 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 69.82% | Gross Margin | 0.7% |
| Operating Margin | -0.18% | Profit Margin | -0.22% |
| ROE | -0.7% | ROA | -0.14% |
| ROCE | -0.14% | Current Ratio | 3.31 |
| Quick Ratio | 3.15 | Cash Ratio | 1.64 |
| Debt/Equity | 1.96 | Interest Coverage | -1.64 |
| Altman Z Score | 4.29 | Piotroski Score | 3 |